Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer
Clinical trial NCT03639948 · UNKNOWN
Trial details
- NCT number
- NCT03639948
- Sponsor
- University of Kansas Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-04
- Primary completion
- 2022-01-27
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.